A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease

被引:31
|
作者
Patchett, Stephanie [1 ]
Lv, Zongyang [2 ]
Rut, Wioletta [3 ]
Bekes, Miklos [1 ,4 ]
Drag, Marcin [3 ]
Olsen, Shaun K. [2 ]
Huang, Tony T. [1 ]
机构
[1] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA
[3] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland
[4] Arvinas Inc, 5 Sci Pk, New Haven, CT 06511 USA
来源
CELL REPORTS | 2021年 / 36卷 / 13期
关键词
RESPIRATORY-SYNDROME-CORONAVIRUS; RECOGNITION; DOMAIN; COV;
D O I
10.1016/j.celrep.2021.109754
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The SARS-CoV-2 papain-like protease (PLpro) is a target for antiviral drug development. It is essential for processing viral polyproteins for replication and functions in host immune evasion by cleaving ubiquitin (Ub) and ubiquitin-like protein (Ubl) conjugates. While highly conserved, SARS-CoV-2 and SARS-CoV PLpro have contrasting Ub/Ubl substrate preferences. Using a combination of structural analyses and functional assays, we identify a molecular sensor within the S1 Ub-binding site of PLpro that serves as a key determinant of substrate specificity. Variations within the S1 sensor specifically alter cleavage of Ub substrates but not of the Ubl interferon-stimulated gene 15 protein (ISG15). Significantly, a variant of concern associated with immune evasion carries a mutation in the S1 sensor that enhances PLpro activity on Ub substrates. Collectively, our data identify the S1 sensor region as a potential hotspot of variability that could alter host antiviral immune responses to newly emerging SARS-CoV-2 lineages.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor
    Kralj, Sebastjan
    Jukic, Marko
    Bahun, Miha
    Kranjc, Luka
    Kolaric, Anja
    Hodoscek, Milan
    Ulrih, Natasa Poklar
    Bren, Urban
    PHARMACEUTICS, 2024, 16 (02)
  • [32] Structure-based design of SARS-CoV-2 papain-like protease inhibitors
    Jadhav, Prakash
    Huang, Bo
    Osipiuk, Jerzy
    Zhang, Xiaoming
    Tan, Haozhou
    Tesar, Christine
    Endres, Michael
    Jedrzejczak, Robert
    Tan, Bin
    Deng, Xufang
    Joachimiak, Andrzej
    Cai, Jianfeng
    Wang, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [33] Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
    Sokolinskaya, Elena L.
    Putlyaeva, Lidia, V
    Polinovskaya, Vasilisa S.
    Lukyanov, Konstantin A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [34] Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
    Donghyuk Shin
    Rukmini Mukherjee
    Diana Grewe
    Denisa Bojkova
    Kheewoong Baek
    Anshu Bhattacharya
    Laura Schulz
    Marek Widera
    Ahmad Reza Mehdipour
    Georg Tascher
    Paul P. Geurink
    Alexander Wilhelm
    Gerbrand J. van der Heden van Noort
    Huib Ovaa
    Stefan Müller
    Klaus-Peter Knobeloch
    Krishnaraj Rajalingam
    Brenda A. Schulman
    Jindrich Cinatl
    Gerhard Hummer
    Sandra Ciesek
    Ivan Dikic
    Nature, 2020, 587 : 657 - 662
  • [35] Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PLpro)
    Taylor, Ashley J.
    Amporndanai, Kangsa
    Rietz, Tyson A.
    Zhao, Bin
    Thiruvaipati, Anusha
    Wei, Qiangqiang
    South, Taylor M.
    Crow, Mackenzie M.
    Apakama, Chideraa
    Sensintaffar, John L.
    Phan, Jason
    Lee, Taekyu
    Fesik, Stephen W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1351 - 1357
  • [36] Unmasking an Allosteric Binding Site of the Papain-like Protease in SARS-CoV-2: Molecular Dynamics Simulations of Corticosteroids
    Panda, Saroj Kumar
    Sen Gupta, Parth Sarthi
    Karmakar, Shaswata
    Biswal, Satyaranjan
    Mahanandia, Nimai Charan
    Rana, Malay Kumar
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2023, 14 (45): : 10278 - 10284
  • [37] High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
    Zang, Yi
    Su, Mingbo
    Wang, Qingxing
    Cheng, Xi
    Zhang, Wenru
    Zhao, Yao
    Chen, Tong
    Jiang, Yingyan
    Shen, Qiang
    Du, Juan
    Tan, Qiuxiang
    Wang, Peipei
    Gao, Lixin
    Jin, Zhenming
    Zhang, Mengmeng
    Li, Cong
    Zhu, Ya
    Feng, Bo
    Tang, Bixi
    Xie, Han
    Wang, Ming-Wei
    Zheng, Mingyue
    Pan, Xiaoyan
    Yang, Haitao
    Xu, Yechun
    Wu, Beili
    Zhang, Leike
    Rao, Zihe
    Yang, Xiuna
    Jiang, Hualiang
    Xiao, Gengfu
    Zhao, Qiang
    Li, Jia
    PROTEIN & CELL, 2023, 14 (01) : 17 - 27
  • [38] Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
    Qiu, Yue
    Liu, Qing
    Tu, Gao
    Yao, Xiao-Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [39] Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
    Ibrahim, Tamer M.
    Ismail, Muhammad I.
    Bauer, Matthias R.
    Bekhit, Adnan A.
    Boeckler, Frank M.
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [40] Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2
    Waqas, Muhammad
    Ullah, Saeed
    Halim, Sobia Ahsan
    Rehman, Najeeb Ur
    Ali, Amjad
    Jan, Afnan
    Bin Muhsinah, Abdullatif
    Khan, Ajmal
    Al-Harrasi, Ahmed
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 258